Saturday, December 6, 2025

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

Seoul Downplays Kim Jong Un’s APEC Attendance, Casts Trump as Key to Reviving Talks

South Korea remains cautious about Kim Jong Un's APEC attendance, emphasizing Trump's role in potential U.S.-North Korea talks.

UN Security Council Convenes Amid North Korean Human Rights Concerns

The UN Security Council (UNSC) convened a...

Tag: pharmacokinetics

North KoreaKoreaKimSouth KoreaMilitaryAImarketchinaRussia

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

Tumors Shrinking, Hopes Rising: Voronoi’s VRN11 Shows Over 40% Tumor Reduction in Early Lung Cancer Trial

Voronoi's VRN11 shows promising anti-cancer efficacy in early trials, reducing tumors in resistant lung cancer patients without major side effects.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.